Somaxon Pharmaceuticals, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Somaxon Pharmaceuticals, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Somaxon Pharmaceuticals, Inc.. The Company's principal activity is that of licensing, development and commercialization of proprietary branded products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Its product candidates are Silenor is in Phase 3 clinical trials for the treatment of insomnia, Nalmefene hydrochloride is in a Phase 2/3 clinical trial for the treatment of pathological gambling and a Phase 2 clinical trial for smoking cessation. The Company is also developing a new formulation of Acamprosate Calcium for the treatment of certain movement disorders.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report